[grey_whiskers]

A simple molecule binding to a receptor is arguably different from a larger molecule mimicking a protein.

Your issue of clinical science and corruption and integrity comes in because most of the simple molecules are off-patent such that it is not as easy to print money with them as it is with a new (untested) mRNA product.

Incidentally, you might enjoy these articles on Moderna...

https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/

https://www.barnhardt.biz/2021/08/11/thermonuclear-for-aggressive-distribution-september-arsh-2016-article-on-moderna-that-is-one-of-the-most-damning-things-i-have-ever-read/

https://www.statnews.com/2017/01/10/moderna-trouble-mrna/

One of those might point to another, I’m in too much of a hurry to double-check right now.

[ifinnegan]

“Your issue of clinical science and corruption and integrity comes in because most of the simple molecules are off-patent such that it is not as easy to print money with them as it is with a new (untested) mRNA product.”

That can happen as easily with new small molecule drugs.

[Pelham]

You still pretending to be a doctor?